Bolt Biotherapeutics, Inc. (BOLT) vs Dare Bioscience, Inc. (DARE)

Bolt Biotherapeutics, Inc. and Dare Bioscience, Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and Dare Bioscience, Inc. are of similar size ($12.3M and $12.3M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against 12.8%. Bolt Biotherapeutics, Inc. has the higher net margin (−611.5% vs −804.3%) and the lower return on invested capital (−143.8% vs 0.00%). Across the 17 metrics below, Bolt Biotherapeutics, Inc. leads on 11 and Dare Bioscience, Inc. on 6.

Valuation

Metric BOLT DARE Biotechnology median
P/E n/m n/m 10.26
P/S 2.35 6.76 9.18
P/B 0.87 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 2.51 3.64 8.98
Earnings yield (251.76%) (125.90%) (34.89%)
Free cash flow yield (279.10%) (125.68%) (24.52%)

Profitability

Metric BOLT DARE Biotechnology median
Gross margin 100.00% 58.84% 65.16%
Operating margin (654.53%) (813.35%) 0.00%
Net margin (611.47%) (804.33%) 0.00%
Free cash flow margin (655.72%) (849.36%) 0.00%
Return on equity (111.65%) 165.29% (50.12%)
Return on assets (49.62%) (62.16%) (45.60%)
Return on invested capital (143.75%) 0.00% 0.00%

Growth

Metric BOLT DARE Biotechnology median
Revenue growth (TTM) 12.79% 7,817.51% 6.26%
EPS growth (last fiscal year) 45.91% (150.00%) 29.88%
Revenue growth, 5-year CAGR 101.61% 66.71% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BOLT DARE Biotechnology median
Debt to equity 1.47 0.00 0.00
Current ratio 2.61 0.99 4.89
Net debt to EBITDA 0.21 2.07 1.01

Dividend

Metric BOLT DARE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BOLT DARE Biotechnology median
Market cap 12.29m 12.27m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack